Accéder au contenu
Merck

Antibiotic biosynthesis: from natural to unnatural compounds.

Journal of industrial microbiology & biotechnology (2002-01-10)
H G Floss
RÉSUMÉ

The evolution of the field of biosynthesis from the unravelling of the mode of formation of natural products to the use of such knowledge to create new compounds is reviewed using examples from the author's laboratory. The discussion focuses on the mode of operation of type II (spore pigment PKS) and type I (rifamycin PKS) polyketide synthases and their diversion to generate unnatural products, and on the genetics and biochemistry of deoxysugar formation in granaticin biosynthesis as a prerequisite to combinatorial enzymatic synthesis of unusual glycosides.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Rifamycin B, European Pharmacopoeia (EP) Reference Standard